|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.10 / 0.19|
With the market bouncing, the crew offers their best stock picks and the safest haven.
Health care stocks are flat, despite a solid gain by Bradley and a fall by Cortex.
An iPod insider trading scandal, and should you take a bite of Apple here?
The companies will invest as much as 'several hundred million dollars' to conduct more research of the tumor drug.
Here's a list of stocks set to report phase III trial results.
The buyout failure highlights top executives' poor choices.
Research suggests a lower dosage of the cancer drug works better with a high-fat meal.
Stocks soar into record territory amid more M&A and strong same-store sales. Helene Meisler and James "Rev Shark" De Porre provide insights.
Using China as a comparison, it's clear biotech is undervalued currently.
Brocade, ImClone and Penske downgraded; NRG and Advance America upgraded.
Results don't suggest a significant market-share assault on Genentech's Avastin.
This week, ASCO's clinical-data leaks, and why they blacklisted Adam.
ASCO officials are dismayed confidential data are finding their way into traders' hands.
Volatility in stocks shows some investors already trading on 'confidential' research.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.